Sloy Dahl & Holst’s Medtronic MDT Stock Holding History

Sloy Dahl & Holst’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,118	Closed	-$265K	–	94
2021 Q4	$265K	Hold	2,118	–	–	0.06%	74
2021 Q3	$265K	Buy	+2,118	New	+$274K	0.06%	74

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Sloy Dahl & Holst's MDT Position: Q1 2022 in Review

Sloy Dahl & Holst sold out of Medtronic (MDT) in Q1 2022, closing a stake of 2,118 shares — an estimated $265K sold.

Sloy Dahl & Holst first reported a position in MDT in Q3 2021 and held it in 2 quarters. The position peaked at $265K in Q4 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

Sloy Dahl & Holst reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
Sloy Dahl & Holst sold 2,118 Medtronic shares in Q1 2022, an estimated $265K.
Sloy Dahl & Holst first reported a position in Medtronic in Q3 2021 and held it in 2 quarters.
Sloy Dahl & Holst's Medtronic position peaked at $265K in Q4 2021.
2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Sloy Dahl & Holst's 13F filing for Q1 2022, filed 10 May 2022.